IMU 8.51% 4.3¢ imugene limited

Media Thread, page-7101

  1. 6,434 Posts.
    lightbulb Created with Sketch. 5274
    Hi Capt,

    Will you be at the Sydney one?

    A couple of interesting articles out & apologies if already posted. Merck are shopping NOW knowing the patent cliff for Keytruda is coming (2028 according to the article). A collaboration with Moderna, they have shelved Cavatak, what’s going on, a better oncolytic viral tech coming lol? Seagen deal has fallen through due to differing valuations (fair enough, if Merck want their pipeline too cheaply, SH want value too).

    https://www.fiercebiotech.com/biotech/merck-ditches-cavatak-more-four-years-after-buying-viralytics

    https://www.reuters.com/business/healthcare-pharmaceuticals/merck-third-quarter-earnings-climb-lifts-full-year-outlook-2022-10-27/

    https://www.fiercepharma.com/pharma/merck-and-seagen-cant-agree-price-their-rumored-merger-bloomberg

    A few brief & interesting articles to take a look at in our Oncology Space.

    Have a lovely Sunday folks. No guarantees or investment advice, something to read over your morning coffee.

 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
4.3¢
Change
-0.004(8.51%)
Mkt cap ! $319.8M
Open High Low Value Volume
4.6¢ 4.6¢ 4.3¢ $2.112M 47.68M

Buyers (Bids)

No. Vol. Price($)
40 6781697 4.3¢
 

Sellers (Offers)

Price($) Vol. No.
4.4¢ 315883 2
View Market Depth
Last trade - 16.10pm 31/10/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.